← back to search

Jussi Taipale

Wellcome Sanger Institute · GB
Area of research
Molecular Biology · Pathology and Forensic Medicine
Research interest
Research interests include Genomics and Chromatin Dynamics, Genetic factors in colorectal cancer, Cancer Genomics and Diagnostics, and RNA and protein synthesis mechanisms.
h-index
76
citations
38,286
works
261
NIH funding
primary concept
Biology
email

Recent publications

DNA-guided transcription factor interactions extend human gene regulatory code
Nature 2025cited by 41position: lastdoi
DNA-guided transcription factor cooperativity shapes face and limb mesenchyme
Cell 2024cited by 78position: middledoi
DNA methylation patterns of transcription factor binding regions characterize their functional and evolutionary contexts
Genome biology 2024cited by 36position: middledoi
Author Correction: Myt1l safeguards neuronal identity by actively repressing many non-neuronal fates
Nature 2024cited by 1position: middledoi
Hold out the genome: a roadmap to solving the cis-regulatory code
Nature 2023cited by 96position: lastdoi
Pioneer factors — key regulators of chromatin and gene expression
Nature Reviews Genetics 2023cited by 54position: middledoi
Sequence determinants of human gene regulatory elements
Nature Genetics 2022cited by 220position: lastdoi
DNA methylation patterns of transcription factor binding regions characterize their functional and evolutionary contexts
bioRxiv (Cold Spring Harbor Laboratory) 2022cited by 5position: middledoi
Genetic and Epigenetic Characteristics of Inflammatory Bowel Disease–Associated Colorectal Cancer
Gastroenterology 2021cited by 214position: middledoi
Systematic analysis of binding of transcription factors to noncoding variants
Nature 2021cited by 175position: middledoi
Human cell transformation by combined lineage conversion and oncogene expression
Oncogene 2021cited by 39position: lastdoi
Structural insights into the interaction between transcription factors and the nucleosome
Current Opinion in Structural Biology 2021cited by 35position: lastdoi
Promoter Hypermethylation Promotes the Binding of Transcription Factor NFATc1, Triggering Oncogenic Gene Activation in Pancreatic Cancer
Cancers 2021cited by 11position: middledoi
Author Correction: CRISPR-assisted detection of RNA–protein interactions in living cells
Nature Methods 2021cited by 1position: middledoi
A comprehensive library of human transcription factors for cell fate engineering
Nature Biotechnology 2020cited by 240position: middledoi
CRISPR-assisted detection of RNA–protein interactions in living cells
Nature Methods 2020cited by 141position: middledoi
Impact of constitutional TET2 haploinsufficiency on molecular and clinical phenotype in humans
Nature Communications 2019cited by 93position: middledoi
Gain-of-function CEBPE mutation causes noncanonical autoinflammatory inflammasomopathy
Journal of Allergy and Clinical Immunology 2019cited by 55position: middledoi
The transcription factor FLI1 promotes cancer progression by affecting cell cycle regulation
International Journal of Cancer 2019cited by 22position: middledoi
The Human Transcription Factors
Cell 2018cited by 3,581position: middledoi
CRISPR–Cas9 genome editing induces a p53-mediated DNA damage response
Nature Medicine 2018cited by 1,258position: lastdoi
The interaction landscape between transcription factors and the nucleosome
Nature 2018cited by 389position: lastdoi
Promoter capture Hi-C-based identification of recurrent noncoding mutations in colorectal cancer
Nature Genetics 2018cited by 75position: middledoi
Two distinct DNA sequences recognized by transcription factors represent enthalpy and entropy optima
eLife 2018cited by 59position: lastdoi
Impact of cytosine methylation on DNA binding specificities of human transcription factors
Science 2017cited by 1,328position: lastdoi
Structural perspective of cooperative transcription factor binding
Current Opinion in Structural Biology 2017cited by 263position: lastdoi
Myt1l safeguards neuronal identity by actively repressing many non-neuronal fates
Nature 2017cited by 246position: middledoi
Transcription factor family‐specific DNA shape readout revealed by quantitative specificity models
Molecular Systems Biology 2017cited by 133position: middledoi
Damaging heterozygous mutations in NFKB1 lead to diverse immunologic phenotypes
Journal of Allergy and Clinical Immunology 2017cited by 120position: middledoi
CRISPR/Cas9 screening using unique molecular identifiers
Molecular Systems Biology 2017cited by 87position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Ekaterina Morgunova · Karolinska Institutet13 papers (2012–2025)Arttu Jolma · University of Toronto13 papers (2013–2024)Teemu Kivioja · University of Helsinki11 papers (2012–2022)Yimeng Yin · Boston College11 papers (2015–2025)Jian Yan · Chinese Academy of Medical Sciences & Peking Union Medical College10 papers (2012–2021)Minna Taipale · Trinity House9 papers (2012–2018)Eevi Kaasinen · University of Helsinki8 papers (2012–2022)Kazuhiro R. Nitta · Hiroshima General Hospital8 papers (2013–2024)Kashyap Dave · Karolinska Institutet8 papers (2013–2022)Lauri A. Aaltonen · University of Helsinki8 papers (2012–2021)А. Н. Попов · Russian Academy of Sciences7 papers (2015–2025)Martin Enge · Karolinska Institutet6 papers (2012–2016)Jilin Zhang · Tung Wah College6 papers (2017–2024) · 5 papers (2012–2016)Inderpreet Sur · Karolinska Institutet5 papers (2012–2017)Kimmo Palin · University of Helsinki5 papers (2013–2021)Mikko Turunen · Columbia University Irving Medical Center4 papers (2012–2017)Thomas Whitington · Karolinska Institutet4 papers (2013–2014) · 4 papers (2013–2015)Riku Katainen · Institute for Molecular Medicine Finland4 papers (2013–2015)